Latest "Shore Tilbe Irwin & Partners" News Stories

06:35 EST 15th December 2018 | BioPortfolio

Here are the most relevant search results for "Shore Tilbe Irwin & Partners" found in our extensive news archives from over 250 global news sources.

More Information about Shore Tilbe Irwin & Partners on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Shore Tilbe Irwin & Partners for you to read. Along with our medical data and news we also list Shore Tilbe Irwin & Partners Clinical Trials, which are updated daily. BioPortfolio also has a large database of Shore Tilbe Irwin & Partners Companies for you to search.

Showing "Shore Tilbe Irwin Partners" News Articles 1–25 of 4,800+

Saturday 15th December 2018

With Losses Mounting, MabVax Therapeutics Looks to Sell Off Assets

MabVax Therapeutics says it doesn’t have enough money to continue funding its operations. The San Diego biotech company, which is testing an antibody discovery platform intended to speed products to patients with cancer and pancreatitis, said Thursday it has retained a local investment banking firm, Objective Capital Partners, to guide its sale. As of Sept. […]

Friday 14th December 2018

Systems Oncology Announces Pipeline of Innovative Drugs Emerging from the Use of Artificial Intelligence

Dr. Spyro Mousses, CEO of Systems Oncology, LLC, announced Systems Oncology’s diversified pipeline of innovative oncology programs discovered with the help of Artificial Intelligence at the AIMed North America Conference in Dana Point, California. Systems Oncology, an AI-based biopharmaceutical company, utilizes computational tools and machine l...

NACDS grant partners increase adult vaccination awareness

Laboratoires Thea SA Strategic SWOT Analysis Review [Report Updated: 31102018] Prices from USD $125

Laboratoires Thea SA Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your busines...

Edmonton to Host Clinical Trial for Nova Oculus Medical Device that Could Help Improve Vision for AMD Sufferers

Health Canada approves study for pioneering treatment EDMONTON, Alberta (PRWEB) December 14, 2018 NOVA OCULUS PARTNERS, LLC, and its Canadian partner, the Eye Machine Canada Inc., have been given the green light to immediately begin a clinical patient trial in Edmonton using their pioneering technology for treating Age-Related Macular Degeneration (AMD). The medical devices bureau of Health Canad...

Prestige BioPharma Partners with Cipla to Market Key Cancer Biosimilar

NewsThe licensing agreement for the HD20 trastuzumab biosimilar gives Cipla Ltd. exclusive rights to distribute and market the drug in selected emerging markets.

Kurma’s BioFund Returns for Third Round

The French venture capital firm Kurma Partners completed the first closing of its biggest fund so far, expected to total €150M. The fund will focus on helping companies developing therapeutics for rare diseases. The expected end amount of the new ... The post Kurma’s BioFund Returns for Third Round appeared first on

Merck to Acquire Privately Held Antelliq Group for $2.4 Billion

KENILWORTH, N.J., & VITRÉ, France–(BUSINESS WIRE)–Merck [NYSE:MRK], known as MSD outside the United States and Canada, and privately held Antelliq Group today announced that the companies have signed a definitive agreement under which Merck will acquire Antelliq from funds advised by BC Partners. Antelliq will be a wholly owned and separately operated subsidiary within the …

Guardant Health Partners with AstraZeneca to Develop Blood-Based Companion Diagnostic Tests for Tagrisso and Imfinzi

REDWOOD CITY, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) — Guardant Health (Nasdaq: GH) announced a multi-year agreement with AstraZeneca (NYSE: AZN) to develop blood-based companion diagnostic (CDx) tests supporting the commercialization of AstraZeneca’s oncology portfolio based on Guardant’s industry-leading comprehensive liquid biopsy platform. Under the terms of the agreement, Guardant H...

Healogics, Inc. Names David Jollow as Chief Information Security Officer

Healogics, the nation’s largest provider of advanced chronic wound care services, today announced that it has appointed David Jollow to serve as Chief Information Security Officer. In this role, Jollow will conduct assessments of current IT security and risks, and provide next generation security solutions. He will also be responsible for enhancing, impl...

Members of Partnership for Maternal, Newborn Child Health make significant commitments post ...

GENEVA and NEW DELHI, Dec. 14, 2018 /PRNewswire/ -- Two days of deliberations, discussions and spirited exchanges at the 2018 Partners' Forum in New Delhi Read more...

ASGARD Partners Co. Advises Global Knowledge Training on $10 Million Receivables Facility

NEW YORK, Dec. 14, 2018 /PRNewswire/ -- ASGARD Partners & Co. ("ASGARD") is pleased to announce that is has advised Global Knowledge Training LLC ("Global Read more...

Merck To Buy Antelliq For EUR 2.1 Bln Plus Debt Of EUR 1.15 Bln

KENILWORTH (NJ) (dpa-AFX) - Merck & Co. Inc. (MRK) said that it agreed to acquire privately held Antelliq Group from funds advised by BC Partners.Merck said it will make a cash payment of approxim...

Merck to Acquire Privately Held Antelliq Group

Establishes Merck Animal Health as a Leader in Emerging Digital Tracking, Traceability and Monitoring Technology Complements Merck Animal Health Portfolio of Vaccines and Pharmaceuticals Merck [NYSE:MRK], known as MSD outside the United States and Canada, and privately held Antelliq Group today announced that the companies have signed a...

Shore Capital Group (SGR) - Diversified business model

Edison Investment Research - Financials - Shore Capital Group: Since its flotation in 2000, Shore Capital has navigated a number of market cycles, generating operating profits throughout this period. More recently, it has continued to grow its franchise, adding further corporate clients and increasing assets under management in the first half of the current year, helped by investment to support cl...

CytoTools: Aussicht auf gute Nachrichten

Den Ausführungen von SMC-Research zufolge stehe bei CytoTools die Freigabe der Produktionsstätte des Partners Centaur in Indien noch aus, die Prüfung befinde sich aber in der finalen Phase. Eine Ge...

AVEO and AstraZeneca Link on Lung Cancer

US biopharma AVEO Oncology is collaborating with Anglo-Swedish drug major AstraZeneca on a combined treatment for liver cancer. The partners will evaluate the safety and efficacy of combining AVEO’s vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) Fotivda (tivozanib) with AstraZeneca’s immunotherapy Imfinzi (durvalumab).

FIT Biotech Oy: FIT Biotech's financial calendar and Annual General Meeting in 2019

FIT Biotech Oy Company release 14.12.2018 at 09:00 AM EET FIT Biotech's financial calendar and Annual General Meeting in 2019During the year 2019, FIT Biotech Oy will publish the Financial Statement release 2018 and Half Year Financial Report 2019 as follows: Financial Statement Release 2018: Thursday 28 February 2019  Half Year Financial Report 1-6/2019: Thursday 5 S...

Becker's Hospital Review Thanks 122 Companies for Supporting Becker's Hospital Review 10th Annual Meeting

CHICAGO (PRWEB) December 14, 2018 Becker's Healthcare and Becker's Hospital Review extends its sincerest gratitude to our corporate partners sponsoring the Becker's Hospital Review 10th Annual Meeting April 1 to 4, 2019, at the Hyatt Regency in Chicago. More than 300 hospital a...

Kotra Industries Berhad KOTRA Financial and Strategic SWOT Analysis Review [Report Updated: 05122018] Prices from USD $125

Kotra Industries Berhad KOTRA Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augm...

Thursday 13th December 2018

Sewage bacteria found lurking in Hudson River sediments

A new study shows that fecal bacteria from sewage are living in far greater quantities in near-shore sediments of the Hudson River than in the water itself.

Emerald Textiles Continues Expansion in California Through the Acquisition of the Assets of MediClean Linen and Laundry in Los Angeles and Launch of a New Facility Build out in Northern California to Serve Expanding California Customer Base

Emerald Textiles, a portfolio company of Los Angeles-based private investment firms Pacific Avenue Capital Partners, LLC (“Pacific Avenue”) and Highland Avenue Funds, LLC (“Highland”), today announces the acquisition of the assets of MediClean Linen and Laundry, a Los Angeles-based healthcare linen service provider. The acquisition expands the foot...

Here is MassChallenge’s 2019 healthtech cohort

Participants in the Boston, Massachusetts-based program will take part in a six-month curriculum that partners the companies with larger Champion organizations that support the startups with product pilots, research assistance and potential investments

Roche partners with Merck to develop companion diagnostic test

Roche will develop companion diagnostic for use with Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, in advanced solid tumors with mismatch repair deficiency (dMMR). Roche tissue diagnostics head Jill German The post Roche partners with Merck to develop companion diagnostic test appeared first on Compelo Medical Devices.

Series B lands $70mm for Akero

Just six months after its $65mm Series A financing, Akero Therapeutics Inc. has now raised $70mm through a Series B round led...

Quick Search


News Quicklinks